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Vermeulen, C., Bertocci, B., Begg, A. C. and Vens, C. Ion-
izing Radiation Sensitivity of DNA Polymerase Lambda-De-
ficient Cells. Radiat. Res. 168, 683–688 (2007).
Ionizing radiation induces a diverse spectrum of DNA le-
sions, including strand breaks and oxidized bases. In mam-
malian cells, ionizing radiation-induced lesions are targets of
non-homologous end joining, homologous recombination, and
base excision repair. In vitro assays show a potential involve-
ment of DNA polymerase lambda in non-homologous end
joining and base excision repair. In this study, we investigated
whether DNA polymerase lambda played a significant role in
determining ionizing radiation sensitivity. Despite increased
sensitivity to hydrogen peroxide, lambda-deficient mouse em-
bryonic fibroblasts displayed equal survival after exposure to
ionizing radiation compared to their wild-type counterparts.
In addition, we found increased sensitivity to the topoisom-
erase inhibitors camptothecin and etoposide in the absence of
polymerase lambda. These results do not reveal a major role
for DNA polymerase lambda in determining radiosensitivity
in vivo.  2007 by Radiation Research Society
INTRODUCTION
Strand breaks and oxidized bases induced in the DNA
by ionizing radiation are critical lesions that, if unrepaired,
can lead to cell killing and mutation. Two complementary
double-strand break (DSB) repair pathways exist in mam-
malian cells, non-homologous end joining (NHEJ) and ho-
mologous recombination (HR). In addition, ionizing radi-
ation-induced lesions are targets of base excision repair
(BER). Deficiencies in all of these pathways lead to in-
creased sensitivity to ionizing radiation, indicating that all
are important for genomic repair. Within these pathways,
DNA polymerases are thought to play a critical role in re-
pair of radiation-induced damage. At least 19 different
DNA polymerases are expressed in mammalian cells. These
polymerases differ from each other according to the spe-
cialized roles they have during replication, DNA repair, by-
pass of DNA damage, and somatic hypermutation. In vitro
1 Address for correspondence: Division of Experimental Therapy, The
Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam,
The Netherlands; e-mail: a.begg@nki.nl.
studies have indicated a potential role of DNA polymerase
lambda in DSB repair and/or BER, although the in vivo
role is unknown.
DNA polymerase lambda is a member of the X family of
DNA polymerases, comprising other enzymes involved in
DNA repair processes such as DNA polymerase beta, poly-
merase mu, and terminal deoxy-nucleotidyl-transferase (TdT).
Due to its bypass polymerase activity on templates with base
lesions such as abasic sites, it has been implicated in transle-
sion synthesis (TLS), a process allowing lesion bypass during
replication. Other data demonstrating repair deficiency when
lacking in a classical in vitro BER assay suggested a possible
contribution in BER, as shown by Braithwaite et al. (1). How-
ever, in earlier studies, DNA polymerase lambda was shown
to be capable of filling gaps and promoting end joining in an
in vitro NHEJ assay (2, 3). Recent data indicate this involve-
ment to be selective for DNA with complementary overhangs
(4, 5). The observed interaction with ligase IV (LigIV) un-
derlines its proposed role in NHEJ (6). Only a few studies
have addressed DNA polymerase lambda’s role in vivo or in
cellular systems. In vivo, polymerase lambda-deficient mice
were viable and fertile. These mice showed normal immu-
noglobulin hypermutation (7). Furthermore, recent data indi-
cated a participation of polymerase lambda in heavy chain
rearrangement (8). Polymerase lambda-deficient embryonic
stem cells did not show hypersensitivity to H2O2 or methyl
methane sulfonate (MMS), ultraviolet (UV) light, or ionizing
radiation (9). However, lambda-deficient mouse embryonic fi-
broblast cells have been found to be hypersensitive to oxi-
dative damage produced by hydrogen peroxide (H2O2) and 5-
hydroxymethyl-2-deoxyuridine (HmdUrd), indicating a po-
tential role in response to oxidative damage and BER (10).
Our own studies have shown a significant role of BER in
determining radiation response (11–13). We showed that BER
deficiency, by DNA polymerase beta deficiency, resulted in
sensitization to ionizing radiation. Consistent with lambda’s
proposed role in NHEJ or BER, Capp et al. showed increased
radiosensitivity in cells expressing a dominant negative to
DNA polymerase lambda (14). In contrast, primary lambda-
deficient mouse embryonic fibroblasts were not found to have
increased sensitivity to ionizing radiation or bleomycin in ear-
lier studies (8). However, strongly reduced proliferation and a
concomitantly reduced percentage of cells in S phase in these
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primary lambda-deficient cells could have influenced survival
after exposure to ionizing radiation. This alteration in prolif-
eration has been attributed to oxidative damage response (8).
Since ionizing radiation induces a DNA damage spectrum that
partly overlaps with the spectrum induced by oxidative dam-
age, we questioned whether the oxidative damage-sensitive
population might have been under-represented in the radiation
response analysis.
Using transformed mouse embryonic fibroblasts with
equal growth and cell cycle phase distribution patterns here,
we show that, despite exhibiting H2O2 hypersensitivity,
lambda-deficient cells were not more sensitive to ionizing
radiation. In addition, we show increased sensitivity to oth-




Polymerase lambda-deficient mice were generated by Bertocci et al. as
described previously (7). RT-PCR analysis confirmed DNA polymerase
lambda expression status. Transformed polymerase lambda-deficient (pol
/) mouse embryonic fibroblasts and the isogenic wild-type (pol /)
counterparts were generated by the 3T3 protocol from these mice, as
described previously by Bertocci et al. (8). Pol / and pol / cells
were grown at 37C in a 95% air/5% CO2 incubator in Dulbecco’s mod-
ified Eagle’s medium containing 10% fetal calf serum. Growth curves
were obtained after seeding 0.5  104 and 104 cells/well in six-well dishes
in triplicate and counting at various times.
Colony-Forming Survival Assay
Colony-forming survival assays were performed as described previ-
ously (13). Briefly, cells were seeded and, after 6 h, irradiated using a
137Cs irradiation unit at a dose rate of 0.9 Gy/min. For H2O2, camptothecin
and etoposide sensitivity, cells were seeded and treated after 6 h with
H2O2 (Sigma) for 1 h or with camptothecin or etoposide for 2 h in me-
dium without fetal calf serum and antibiotics. Exposure to serum-free
medium for 2 h did not alter S-phase content or replication as measured
by BrdU incorporation determined by flow cytometry (data not shown).
After 1 or 2 h, fresh medium was added and plates were replaced in the
incubator to allow colony formation. Nine days later, cells were fixed,
stained and colonies consisting of 50 cells were counted either manu-
ally under a binocular microscope or using an automatic colony counter
(ColCount, Oxford Optronix, UK). Survival was expressed as colonies
per plated treated cell colonies per plated untreated cell.
In Vitro Cell Growth Inhibition Assay
Cytotoxicity was determined by growth inhibition assays as described
previously (13). Cells were seeded in six-well dishes at a density appro-
priate to maintain exponential growth during the course of the experi-
ment. The following day, cells were exposed to a range of concentrations
of H2O2 (Sigma) for 1 h or camptothecin (Sigma) or etoposide for 2 h in
growth medium without fetal calf serum and antibiotics. After the indi-
cated time of drug treatment, fresh medium was added and dishes were
incubated for 4–5 days until untreated control cells were approximately
75% confluent. Cells (triplicate wells for each drug concentration) were
trypsinized and counted using a cell counter (Casy TT-059, Scha¨rfe Sys-
tem GmbH, Germany). The relative growth inhibition was calculated by
normalizing the average cell number in the drug-treated wells to the con-
trol (percentage control growth). The SF50 (dose needed to reduce the
surviving fraction to 0.5), IC50 (concentration that inhibited growth to
50% of control), and IC10 (concentration that inhibited growth to 10% of
control) were determined from polynomial or power curve fits.
Cell Cycle Phase Determination
Cells were pulse labeled with 1 	M BrdU (Sigma) by incubating for
10 min at 37C. Cells were then trypsinized, resuspended in 1 ml of PBS,
and fixed by adding the cell suspension to 5 ml of ice-cold 70% ethanol.
Anti-BrdU staining was performed as described previously (12). Mea-
surement of the samples and data analysis were performed as described
previously (13).
Genomic Sequence Analysis
Genotyping of pol / and pol / cells was performed by PCR using
primers that amplify the DNA polymerase lambda allele, resulting in a
250-bp fragment in the wild-type cells and a 500-bp fragment in lambda-
deficient cells. Primers were as follows: 5 GCTCCATATGGTTGCTG
GGC and 3 CAGCTCCCCAGATGTTGGAG.
Statistical Analysis
For comparison of differences between the groups, the t test was used
with a significance level of P 
 0.05.
RESULTS
DNA Polymerase Lambda Deficiency Did Not Influence
the Sensitivity to Ionizing Radiation but Sensitized Cells
to H2O2
We first characterized the transformed polymerase lamb-
da-deficient (pol /) mouse embryonic fibroblasts and the
iosogenic wild-type (pol /) counterparts. A genomic
PCR was performed to confirm the genotype of both cell
lines. We found the fragment representing the wild-type
allele (250 bp) in the pol / cells and the polymerase
lambda gene targeted allele (500 bp) in pol / cells (Fig.
1a). Changes in growth or cell cycle phase distribution
could indirectly result in survival differences. However, and
in contrast to the primary cells, both cells lines showed
similar growth rates, with doubling times of 13.4  3.7 h
for wild-type cells and 14.2  1.3 h for pol / cells (mean
values  SD, n  4) (Fig. 1b). Cell cycle phase distribution
was determined by BrdU labeling. Data analysis showed an
S-phase content of 41.2  1.2% and 53.4  4.1%, G1 phase
of 32.4  1.4% and 33.7  6.6%, and G2 phase of 26.4 
0.3% and 12.9  2.5% for wild-type and pol / cells,
respectively. Taken together, no differences were observed
in growth rate and only minor differences were observed
in the cell cycle phase distributions of the cell lines. We
next confirmed sensitivity to H2O2 by determining growth
inhibition. We found that pol / cells were more sensitive
to H2O2 than wild-type cells (Fig. 1c), consistent with its
proposed role in the oxidative damage response. This is in
good concordance with data published previously by
Braithwaite et al. (10) from growth inhibition assays.
With ionizing radiation producing similar oxidative dam-
age, we next determined the survival of polymerase lambda-
deficient cells and wild-type cells after irradiation in a colony-
forming survival assay. We found that pol / cells were not
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FIG. 1. Characterization of pol / cells. Panel A: Genotype of pol / (/) and wild-type (/) cells. Genomic DNA was isolated from both
cell lines, and genotyping was performed by PCR with simultaneous amplification of the wild-type allele (250 bp) and the gene-targeted allele (500
bp). The marker (M) is a 100-bp ladder (Invitrogen). Panel B: Growth of pol / () and wild-type () cells. Cells were seeded, cultured and
counted at the indicated times. A representative growth curve is shown. Panel C: Growth inhibition of pol / () and wild-type () cells after
hydrogen peroxide treatment. Cells were seeded into six-well plates and treated the following day with increasing concentrations of H2O2 for 1 h. After
5 days, cells were counted and the number of H2O2-treated cells was normalized to that of control cells. Percentage control growth is plotted, with
each data point representing the mean and standard deviation of three independent experiments with triplicate samples.
significantly more sensitive to ionizing radiation than the
wild-type cells (Fig. 2a), confirming previous growth inhibi-
tion analyses (8). In contrast, lambda-deficient cells appeared
to be more radioresistant. However, this was significant only
at 6 Gy. We then questioned whether the lack of sensitization
was caused by the assay used, with growth assays emphasiz-
ing growth inhibition rather than killing. We therefore re-
peated the H2O2 sensitivity study with a colony-forming sur-
vival assay. The data confirmed the previous growth inhibition
study, shown in Fig. 1b, with DNA polymerase lambda-de-
ficient cells being significantly more sensitive to H2O2 than
wild-type cells, with SF50 values of 89.1  12.2 	M and 44.9
 4.4 	M (mean values  SD; P  0.004) for wild-type and
pol / cells, respectively, giving a dose ratio of 2.0  0.4
(Fig. 2b). In summary, our data demonstrate no major in-
volvement of DNA polymerase lambda in the response to
ionizing radiation.
Sensitivity of pol / Cells to Camptothecin and
Etoposide
Both damaging agents, H2O2 and ionizing radiation, in-
duce similar oxidative lesions. Nevertheless, lambda-defi-
cient cells exhibited hypersensitivity to H2O2 but surpris-
ingly not to ionizing radiation. This discrepancy prompted
us to analyze two other DNA strand break-inducing agents
without inducing oxidized base damage. For this purpose,
we incubated polymerase lambda-deficient and wild-type
cells with topoisomerase inhibitors. Type I topoisomerase
inhibitors such as camptothecin bind irreversibly to the
DNA-topoisomerase I complex, thereby generating en-
zyme-trapped cleaved DNA. Etoposide, a type II topoisom-
erase inhibitor, enhances double-strand cleavage by com-
plexation with topoisomerase II. We found that pol /
cells showed an increased sensitivity to camptothecin com-
pared to wild-type cells, as determined by growth inhibition
assays (Fig. 3a). The IC10 values were 1.4  0.4 and 0.5
 0.2 	M (mean values  SD; P  0.02) for wild-type
and pol / cells, respectively, with a dose ratio of 3.2 
0.9. Furthermore, pol / cells were significantly more
sensitive to etoposide than wild-type cells (Fig. 3b), with
IC50 values of 1.0  0.1 and 0.6  0.1 	M (P  0.001)
for wild-type and pol / cells, respectively, with a dose
ratio of 1.9  0.4. We repeated the growth inhibition stud-
ies for both drugs with a colony-forming survival assay and
again found that DNA polymerase lambda-deficient cells
were significantly more sensitive than wild-type cells (Fig
3c). As with the growth assays, the surviving fractions of
the cell lines diverged at greater killing after etoposide
treatment. Taken together, these results suggest the involve-
ment of polymerase lambda in the repair of DNA double-
strand breaks of non-oxidative origin.
DISCUSSION
In the present study, we investigated whether DNA poly-
merase lambda played a significant role in determining ion-
izing radiation sensitivity. Previous studies have shown
contradictory results, with a lack of sensitization to ionizing
radiation in lambda-deficient primary cells (8) and hyper-
sensitivity in polymerase lambda dominant negative-ex-
pressing cells. However, studies on the deficient primary
cells may have been hampered by the reduced growth rate
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FIG. 2. Sensitivity of pol / cells to ionizing radiation and H2O2. Panel A: Clonogenic survival of pol / () and wild-type () cells after
exposure to ionizing radiation. Panel B: Clonogenic survival of pol / () and wild-type () cells after exposure to H2O2 for 1 h. After irradiation
or H2O2 exposure, the cells were returned to 37C to allow colonies to develop. Data points are the means and standard deviations of five or three
independent experiments with triplicate samples for panels A and B, respectively.
and considerably increased senescence, in particular when
analyzed by a growth inhibition assay. A potential radio-
sensitive phenotype of the DNA polymerase lambda-defi-
cient cells, in particular in S phase, could have been masked
by a reduction in the S-phase cell population in the lambda-
deficient cells to half of the control level, as observed pre-
viously in the primary cultures. Transformed cells, on the
other hand, probably due to loss of cell cycle checkpoints,
showed similar cell cycle phase distributions and growth
rates for wild-type and lambda-deficient cells (Fig. 1b).
Here we show that these transformed cells did not exhibit
differences in radiation sensitivity (Fig. 2a) despite in-
creased hypersensitivity to hydrogen peroxide. This indi-
cates that the cells did not greatly adapt (due to selection)
to oxidative damage during culture, thereby altering the ox-
idative damage response and/or repair. It is worthwhile not-
ing that even though there were differences between the
assays used, the growth inhibition assay (Fig. 1c) and the
colony-forming survival assay (Fig. 2b), the results were
generally in good concordance with each other. Differences
between the two cell lines were similar to the results of by
Braithwaite et al. (10). We observed a slight increase in
radioresistance in DNA polymerase lambda-deficient cells.
Although not significant for most doses, this could have
resulted from the additional 10% of S-phase cells, which
are generally more resistant to ionizing radiation. In con-
clusion, these results suggest that a deficiency in polymer-
ase lambda is associated with an increased sensitivity to
oxidative damage and strand breaks but not when these
lesions are induced by ionizing radiation.
Two other DNA break-inducing agents, camptothecin and
etoposide, both produced more killing in lambda-deficient
cells (Fig. 3). In contrast to our results (Fig. 3c), Capp et al.
found an increased resistance to camptothecin in hamster cells
(CHO cells) expressing a catalytically inactive polymerase
lambda (polDN) (14). In addition, these cells were found to
be more sensitive to ionizing radiation. Interestingly, sensiti-
zation reached levels that were comparable to that of NHEJ
mutant cells. The inactive DNA polymerase lambda is ex-
pected to act in a dominant negative manner in the proposed
repair pathways. It is likely that the mode of action is different
from the lack of repair due to gene deficiency, in analogy
with our polymerase beta dominant negative studies (11–13).
The dominant negative might have the capacity to block al-
ternative backup polymerases and pathways, or it could in-
terfere in processes unrelated to its wild-type lambda protein.
In addition, the origin of the cell lines, mouse fibroblasts and
hamster ovary cells, could result in different responses to
damaging agents.
Based on the data presented here, we can only speculate
on the possible role of lambda. Assuming that the observed
sensitivities result from involvement in a common pathway,
it is feasible that the nature of the lesion dictates DNA
polymerase lambda’s interaction. Double-strand breaks pro-
duced by ionizing radiation are complex, often presenting
as clustered lesions. In contrast, topoisomerase inhibition
will cause breaks complexed to topoisomerases together
with ligatable ends. Second, double-strand break induction
by topoisomerase inhibitors and hydrogen peroxide are
partly connected to replication. Replication could thereby
present a mutual process in the lambda-dependent respons-
es. Homologous recombination-deficient cells have been
shown to be highly sensitive to camptothecin (15). Etopo-
side sensitivity showed a dependence on non-homologous
end joining but also showed some dependence on homol-
ogous recombination (16, 17), indicating that the choice of
pathway in response to the damaging agent might be related
to DNA polymerase lambda dependence. Consistent with
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FIG. 3. Sensitivity of pol / cells to camptothecin and etoposide. Panel A: Pol / () and wild-type () cells were seeded in six-well plates
and treated the following day with increasing concentrations of camptothecin for 2 h. Panel B: Growth inhibition of pol / () and wild-type ()
cells by etoposide was determined as described above. Percentage control cell number is plotted, with each data point, as described for Fig. 1b,
representing the mean and standard deviation of four independent experiments with triplicate samples. An asterisk indicates that the dose was included
in only two of the four experiments. The insets in each panel are the same data with an expanded scale to illustrate the differences at low drug doses.
Panel C: Clonogenic survival of pol / () and wild-type () cells after exposure to camptothecin for 2 h. Panel D: Clonogenic survival of pol
/ () and wild-type () cells after exposure to etoposide for 2 h. Data points are the means and standard deviations of three independent experiments
with triplicate samples for panels C and D.
such an interpretation, ionizing radiation response in most
cell lines is less dependent on homologous recombination
than on non-homologous end joining.
Repair of ionizing radiation damage is highly dependent
on the non-homologous end-joining repair pathway, as
shown by numerous studies, being dependent on the pres-
ence of non-homologous end-joining proteins such as
Ku70/80, DNA-PK and LigIV. The lack of increased sen-
sitivity to ionizing radiation of lambda-deficient cells found
here therefore does not support a hypothesis of lambda’s
sole involvement in non-homologous end joining after ex-
posure to ionizing radiation. Our data rather suggest the
involvement of another redundant polymerase (18). In sum-
mary, DNA polymerase lambda does not play an important
role in determining sensitivity to ionizing radiation, despite
the observed hydrogen peroxide sensitivity and proposed
role in repair of DNA double-strand breaks.
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